HRTX Operating Cash Flow (Statement)

Heron Therapeutics Inc · Operating Cash Flow (Statement)

HRTX logo

HRTX Operating Cash Flow (Statement)

Latest reported-$11.61M
HRTX Cash from Operations (-$3.80M → -$11.61M)
High-resolution chart · PNG

HRTX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-27,591,000
-22,529,000
-58,789,000
-146,912,000
-203,354,000
-184,820,000
-124,580,000
-191,805,000
-170,300,000
-134,097,000
-78,526,000
-60,282,000
-40,763,000
-17,009,000
-7,721,000
-5,483,000
-10,999,000
-24,275,000
-17,281,000
9,181,000
-7,527,000
-7,743,000
-6,525,000
-5,131,000
-6,491,172
-3,116,002
-600,000
-1,500,000
-200,000
-6,100,000
-8,500,000
-8,600,000
-11,700,000
-3,900,000
-3,800,000
-3,400,000
-3,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.